We primarily focus on complex specialty markets. Our project experience covers a wide range of therapeutic areas including

  • Cardiovascular
  • CNS
  • Dermatology
  • Gastrointestinal
  • Hematology
  • Immunology
  • Infectious Diseases
  • Lifestyle Medications
  • Metabolic
  • Oncology
  • Ophthalmology
  • Respiratory
  • Urology

While our therapeutic experience is diverse, we have built highly focused and specialized expertise in the areas below:


  • Key focus area of the firm with in-depth specialized expertise
  • Proven track record with 700+ projects completed (and growing)
  • Global experience (46% US, 16% EU / ROW, 38% global)
  • Strategic work across more than 28 tumor types
  • Project work with more than 75 products including immunotherapies, biomarker-directed therapeutics, cell and gene therapies, other targeted therapies, and chemotherapeutics
  • Unique resources including Oncology Market Entry Strategy and Commercial Models, detailed “Market Maps” for key tumor types, and a “Launch Center of Excellence” with oncology launch tools, plans and roadmaps ready to go
  • Significant and growing body of oncology thought leadership

Central Nervous System

  • Recently launched CNS Center of Excellence with experienced team members
  • In-depth understanding of the unique challenges facing biopharma companies in today’s CNS markets
  • 65+ projects completed (and growing) across a diverse range of indications including neurodegenerative diseases, psychiatric disorders, neuro-genetic diseases, neuro-oncology, and pain
  • Experience encompassing diverse modalities including small molecules, iRNA, antibodies, cell and gene therapies, digital therapeutics, and others
  • Growing body of CNS thought leadership

Rare Diseases

  • Key focus area of the firm: A dedicated “Center of Excellence” with specialized expertise
  • In-depth understanding of the special development and commercial challenges facing rare disease therapies, as well as a keen “rare disease mindset”
  • Service offerings specifically tailored to rare disease needs and challenges
  • Substantial experience across 120+ rare disease projects encompassing a wide range of rare disease areas including neurodegenerative diseases, metabolic disorders, hematological disorders, hereditary disorders, and more
  • Experience across a diverse range of modalities including antibodies and biologics, iRNA, enzyme replacement therapies, cell and gene therapies, and more
  • Significant and growing body of rare disease thought leadership

Digital Therapeutics

  • Recently launched digital therapeutics Center of Excellence with specialized team members
  • In-depth understanding of the complex and rapidly evolving digital health environment
  • Specialized services focused on helping develop, launch, and scale digital health products
  • Proprietary tools, including a comprehensive database of prescription digital therapeutics products
  • More than 30 projects completed for established biopharma and tech companies, as well as start-ups
  • Experience across a diverse range of technologies including mobile apps, AR/VR tech, conversational agents, AI/ML algorithms, wearables, biometric sensors, and virtual care
  • Experience across a wide range of therapeutic areas
  • Growing body of digital health thought leadership


Contact Us to learn more.